Photodynamic therapy (PDT) is a promising new treatment technique which can potentially destroy unwanted and malignant tissues, such as those of cancer. The photodynamic mechanisms of three tetrapyrrole compounds: Mg-purpurin-18, tetra(meso-chlorophenyl)porphyrin (m-TCPP) and 2,7,12,18-tetramethyl-3,8-di[(1-isobutoxyl)ethyl]-13,17-bis[3-di(2-chloroethyl)aminopropyl]porphyrin (TDBP) in acetonitrile were investigated by 355 nm laser flash photolysis. It was found that after laser flash photolysis (LFP), the excited states of TDBP and Mg-purpurin-18 could react with O 2 and 1 O 2 was produced, which proved that TDBP and Mg-purpurin-18 took effects through type II mechanism in PDT. This suggested that TDBP and Mg-purpurin-18 should be suitable for target tissues containing enough O 2 . Mg-purpurin-18 has two extra absorptions at 550 and 700 nm, which means it has broad choices of laser wavelength in PDT. It was also found that m-TCPP could be photoionized when excited with 355 nm laser under N 2 -saturated condition. It could also react with O 2 to produce reactive oxygen species such as superoxide and the peroxide anions, but not 1 O 2 . These were known as the Type I mechanism. So m-TCPP could be used even at low oxygen concentration or more polar environments with good behavior in PDT. From the above studies on the three different tetrapyrrole compounds it could be concluded that the structure of porphin ring takes a main role in PDT. And there was important impact on the photodynamic mechanism for the functional group directly connecting with porphin ring, while little influence for the functional group indirectly connecting with porphin ring. These will be of great value in the discovery of new PDT drugs.